Marc E. Lippman, Director at SEATTLE GENETICS INC /WA (SGEN), sold 22,500 shares at $25.54 ($575K) on 2012-12-05, disclosed to the SEC on 2012-12-07.
Open-market sale of $575k SGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.54 | 7,500 | $192K | 33.3% |
| 2 | $25.54 | 15,000 | $383K | 66.7% |
| Total | $25.54 avg | 22,500 | $575K | 100% |
| Filing → |
| SGEN | SELL | 2019-11-20 | $6.1M | — | Filing → |
| SGEN | SELL | 2018-08-02 | $512K | — | Filing → |
| SGEN | SELL | 2017-11-17 | $174K | — | Filing → |